Botulinum toxin treatment for blepharospasm associated with myasthenia gravis
Identifieur interne : 004151 ( Istex/Corpus ); précédent : 004150; suivant : 004152Botulinum toxin treatment for blepharospasm associated with myasthenia gravis
Auteurs : Kenju Hara ; Akiko Matsuda ; Yuko Kitsukawa ; Keiko Tanaka ; Masatoyo Nishizawa ; Asako TagawaSource :
- Movement Disorders [ 0885-3185 ] ; 2007-07-15.
Url:
DOI: 10.1002/mds.21558
Links to Exploration step
ISTEX:A4AD59E032966B2F4C050C5074E3FCF14C77C650Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Botulinum toxin treatment for blepharospasm associated with myasthenia gravis</title><author><name sortKey="Hara, Kenju" sort="Hara, Kenju" uniqKey="Hara K" first="Kenju" last="Hara">Kenju Hara</name><affiliation><mods:affiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</mods:affiliation></affiliation></author><author><name sortKey="Matsuda, Akiko" sort="Matsuda, Akiko" uniqKey="Matsuda A" first="Akiko" last="Matsuda">Akiko Matsuda</name><affiliation><mods:affiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</mods:affiliation></affiliation></author><author><name sortKey="Kitsukawa, Yuko" sort="Kitsukawa, Yuko" uniqKey="Kitsukawa Y" first="Yuko" last="Kitsukawa">Yuko Kitsukawa</name><affiliation><mods:affiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</mods:affiliation></affiliation></author><author><name sortKey="Tanaka, Keiko" sort="Tanaka, Keiko" uniqKey="Tanaka K" first="Keiko" last="Tanaka">Keiko Tanaka</name><affiliation><mods:affiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</mods:affiliation></affiliation></author><author><name sortKey="Nishizawa, Masatoyo" sort="Nishizawa, Masatoyo" uniqKey="Nishizawa M" first="Masatoyo" last="Nishizawa">Masatoyo Nishizawa</name><affiliation><mods:affiliation>E-mail: nishi@bri.niigata‐u.ac.jp</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</mods:affiliation></affiliation></author><author><name sortKey="Tagawa, Asako" sort="Tagawa, Asako" uniqKey="Tagawa A" first="Asako" last="Tagawa">Asako Tagawa</name><affiliation><mods:affiliation>Department of Immunology, National Institute of Neuroscience, NCNP, Japan</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A4AD59E032966B2F4C050C5074E3FCF14C77C650</idno><date when="2007" year="2007">2007</date><idno type="doi">10.1002/mds.21558</idno><idno type="url">https://api.istex.fr/document/A4AD59E032966B2F4C050C5074E3FCF14C77C650/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">004151</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Botulinum toxin treatment for blepharospasm associated with myasthenia gravis</title><author><name sortKey="Hara, Kenju" sort="Hara, Kenju" uniqKey="Hara K" first="Kenju" last="Hara">Kenju Hara</name><affiliation><mods:affiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</mods:affiliation></affiliation></author><author><name sortKey="Matsuda, Akiko" sort="Matsuda, Akiko" uniqKey="Matsuda A" first="Akiko" last="Matsuda">Akiko Matsuda</name><affiliation><mods:affiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</mods:affiliation></affiliation></author><author><name sortKey="Kitsukawa, Yuko" sort="Kitsukawa, Yuko" uniqKey="Kitsukawa Y" first="Yuko" last="Kitsukawa">Yuko Kitsukawa</name><affiliation><mods:affiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</mods:affiliation></affiliation></author><author><name sortKey="Tanaka, Keiko" sort="Tanaka, Keiko" uniqKey="Tanaka K" first="Keiko" last="Tanaka">Keiko Tanaka</name><affiliation><mods:affiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</mods:affiliation></affiliation></author><author><name sortKey="Nishizawa, Masatoyo" sort="Nishizawa, Masatoyo" uniqKey="Nishizawa M" first="Masatoyo" last="Nishizawa">Masatoyo Nishizawa</name><affiliation><mods:affiliation>E-mail: nishi@bri.niigata‐u.ac.jp</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</mods:affiliation></affiliation></author><author><name sortKey="Tagawa, Asako" sort="Tagawa, Asako" uniqKey="Tagawa A" first="Asako" last="Tagawa">Asako Tagawa</name><affiliation><mods:affiliation>Department of Immunology, National Institute of Neuroscience, NCNP, Japan</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2007-07-15">2007-07-15</date><biblScope unit="vol">22</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="1363">1363</biblScope><biblScope unit="page" to="1364">1364</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">A4AD59E032966B2F4C050C5074E3FCF14C77C650</idno><idno type="DOI">10.1002/mds.21558</idno><idno type="ArticleID">MDS21558</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Kenju Hara MD, PhD</name><affiliations><json:string>Department of Neurology, Brain Research Institute, Niigata University, Japan</json:string></affiliations></json:item><json:item><name>Akiko Matsuda MD</name><affiliations><json:string>Department of Neurology, Brain Research Institute, Niigata University, Japan</json:string></affiliations></json:item><json:item><name>Yuko Kitsukawa MD</name><affiliations><json:string>Department of Neurology, Brain Research Institute, Niigata University, Japan</json:string></affiliations></json:item><json:item><name>Keiko Tanaka MD, PhD</name><affiliations><json:string>Department of Neurology, Brain Research Institute, Niigata University, Japan</json:string></affiliations></json:item><json:item><name>Masatoyo Nishizawa MD, PhD</name><affiliations><json:string>E-mail: nishi@bri.niigata‐u.ac.jp</json:string><json:string>Department of Neurology, Brain Research Institute, Niigata University, Japan</json:string></affiliations></json:item><json:item><name>Asako Tagawa MD, PhD</name><affiliations><json:string>Department of Immunology, National Institute of Neuroscience, NCNP, Japan</json:string></affiliations></json:item></author><genre><json:string>Serial article</json:string></genre><host><volume>22</volume><pages><total>2</total><last>1364</last><first>1363</first></pages><issn><json:string>0885-3185</json:string></issn><issue>9</issue><subject><json:item><value>Letters to the Editor</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><language><json:string>eng</json:string></language><qualityIndicators><score>1.001</score><pdfVersion>1.3</pdfVersion><pdfPageSize>594 x 792 pts</pdfPageSize><refBibsNative>false</refBibsNative><abstractCharCount>0</abstractCharCount><pdfWordCount>951</pdfWordCount><pdfCharCount>6376</pdfCharCount><pdfPageCount>2</pdfPageCount><abstractWordCount>0</abstractWordCount></qualityIndicators><title>Botulinum toxin treatment for blepharospasm associated with myasthenia gravis</title><publicationDate>2007</publicationDate><copyrightDate>2007</copyrightDate><doi><json:string>10.1002/mds.21558</json:string></doi><id>A4AD59E032966B2F4C050C5074E3FCF14C77C650</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/A4AD59E032966B2F4C050C5074E3FCF14C77C650/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/A4AD59E032966B2F4C050C5074E3FCF14C77C650/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/A4AD59E032966B2F4C050C5074E3FCF14C77C650/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Botulinum toxin treatment for blepharospasm associated with myasthenia gravis</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>2007</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Botulinum toxin treatment for blepharospasm associated with myasthenia gravis</title><author><persName><forename type="first">Kenju</forename><surname>Hara</surname><roleName type="degree">MD, PhD</roleName></persName><affiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</affiliation></author><author><persName><forename type="first">Akiko</forename><surname>Matsuda</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</affiliation></author><author><persName><forename type="first">Yuko</forename><surname>Kitsukawa</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</affiliation></author><author><persName><forename type="first">Keiko</forename><surname>Tanaka</surname><roleName type="degree">MD, PhD</roleName></persName><affiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</affiliation></author><author><persName><forename type="first">Masatoyo</forename><surname>Nishizawa</surname><roleName type="degree">MD, PhD</roleName></persName><email>nishi@bri.niigata‐u.ac.jp</email><affiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</affiliation></author><author><persName><forename type="first">Asako</forename><surname>Tagawa</surname><roleName type="degree">MD, PhD</roleName></persName><affiliation>Department of Immunology, National Institute of Neuroscience, NCNP, Japan</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2007-07-15"></date><biblScope unit="vol">22</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="1363">1363</biblScope><biblScope unit="page" to="1364">1364</biblScope></imprint></monogr><idno type="istex">A4AD59E032966B2F4C050C5074E3FCF14C77C650</idno><idno type="DOI">10.1002/mds.21558</idno><idno type="ArticleID">MDS21558</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2007</date></creation><langUsage><language ident="en">en</language></langUsage><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Letters to the Editor</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2007-07-15">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/A4AD59E032966B2F4C050C5074E3FCF14C77C650/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="subtitle">Official Journal of the Movement Disorder Society</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="90"><doi origin="wiley" registered="yes">10.1002/mds.v22:9</doi><numberingGroup><numbering type="journalVolume" number="22">22</numbering><numbering type="journalIssue">9</numbering></numberingGroup><coverDate startDate="2007-07-15">15 July 2007</coverDate></publicationMeta><publicationMeta level="unit" type="letter" position="310" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.21558</doi><idGroup><id type="unit" value="MDS21558"></id></idGroup><countGroup><count type="pageTotal" number="2"></count></countGroup><titleGroup><title type="articleCategory">Letters to the Editor</title><title type="tocHeading1">Letters to the Editor Related to New Topics</title></titleGroup><copyright ownership="thirdParty">Copyright © 2007 Movement Disorder Society</copyright><eventGroup><event type="publishedOnlineEarlyUnpaginated" date="2007-05-07"></event><event type="firstOnline" date="2007-05-07"></event><event type="publishedOnlineFinalForm" date="2007-07-23"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:FullText result:FullText" date="2010-03-09"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">1363</numbering><numbering type="pageLast">1364</numbering></numberingGroup><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS21558.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="1"></count><count type="tableTotal" number="0"></count><count type="referenceTotal" number="7"></count><count type="wordTotal" number="873"></count></countGroup><titleGroup><title type="main" xml:lang="en">Botulinum toxin treatment for blepharospasm associated with myasthenia gravis</title><title type="short" xml:lang="en">Letters to the Editor</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Kenju</givenNames><familyName>Hara</familyName><degrees>MD, PhD</degrees></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Akiko</givenNames><familyName>Matsuda</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Yuko</givenNames><familyName>Kitsukawa</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Keiko</givenNames><familyName>Tanaka</familyName><degrees>MD, PhD</degrees></personName></creator><creator xml:id="au5" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Masatoyo</givenNames><familyName>Nishizawa</familyName><degrees>MD, PhD</degrees></personName><contactDetails><email normalForm="nishi@bri.niigata-u.ac.jp">nishi@bri.niigata‐u.ac.jp</email></contactDetails></creator><creator xml:id="au6" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Asako</givenNames><familyName>Tagawa</familyName><degrees>MD, PhD</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="JP" type="organization"><unparsedAffiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="JP" type="organization"><unparsedAffiliation>Department of Immunology, National Institute of Neuroscience, NCNP, Japan</unparsedAffiliation></affiliation><affiliation xml:id="af3" countryCode="JP" type="organization"><unparsedAffiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</unparsedAffiliation></affiliation><affiliation xml:id="af4" countryCode="JP" type="organization"><unparsedAffiliation>Department of Immunology, National Institute of Neuroscience, NCNP, Japan</unparsedAffiliation></affiliation></affiliationGroup></contentMeta></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 3-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Botulinum toxin treatment for blepharospasm associated with myasthenia gravis</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Letters to the Editor</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Botulinum toxin treatment for blepharospasm associated with myasthenia gravis</title></titleInfo><name type="personal"><namePart type="given">Kenju</namePart><namePart type="family">Hara</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Akiko</namePart><namePart type="family">Matsuda</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Yuko</namePart><namePart type="family">Kitsukawa</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Keiko</namePart><namePart type="family">Tanaka</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Masatoyo</namePart><namePart type="family">Nishizawa</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>E-mail: nishi@bri.niigata‐u.ac.jp</affiliation><affiliation>Department of Neurology, Brain Research Institute, Niigata University, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Asako</namePart><namePart type="family">Tagawa</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Immunology, National Institute of Neuroscience, NCNP, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">letter</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2007-07-15</dateIssued><copyrightDate encoding="w3cdtf">2007</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">1</extent><extent unit="references">7</extent><extent unit="words">873</extent></physicalDescription><relatedItem type="host"><titleInfo><title>Movement Disorders</title><subTitle>Official Journal of the Movement Disorder Society</subTitle></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><subject><genre>article category</genre><topic>Letters to the Editor</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><detail type="issue"><caption>no.</caption><number>9</number></detail><extent unit="pages"><start>1363</start><end>1364</end><total>2</total></extent></part></relatedItem><identifier type="istex">A4AD59E032966B2F4C050C5074E3FCF14C77C650</identifier><identifier type="DOI">10.1002/mds.21558</identifier><identifier type="ArticleID">MDS21558</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2007 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004151 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 004151 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:A4AD59E032966B2F4C050C5074E3FCF14C77C650
|texte= Botulinum toxin treatment for blepharospasm associated with myasthenia gravis
}}
| This area was generated with Dilib version V0.6.23. |  |